PACB — Pacific Biosciences of California, Inc. Dilution Risk Tracker

Pacific Biosciences of California, Inc. (PACB) has a DilutionScore of 41/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 28, 2026.

DilutionWatch tracks 4.2M outstanding warrants for PACB. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: PACB has approximately 13 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for PACB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for PACB alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.